Effects of aldehyde-modified proteins on mesangial cell-matrix interaction
- PMID: 8013260
- DOI: 10.1016/0168-8227(94)90123-6
Effects of aldehyde-modified proteins on mesangial cell-matrix interaction
Abstract
We examined the effect of aldehyde-modified matrix macromolecules on mesangial cell function in vitro, using incubated rat glomerular mesangial cells. Laminin and fibronectin were modified by incubation for 24 h with 50 mM glycolaldehyde (GA), a highly reactive cross-linking glycation product, with or without equimolar aminoguanidine. GA-modified laminin and fibronectin caused marked inhibition of cell adhesion. Cell spreading was reduced on the GA-modified laminin. In contrast, the GA-modified fibronectin had no effect on cell spreading. The study of thymidine incorporation by mesangial cells showed that the GA-modified fibronectin had a diminished mitogenic activity against cells. The content of advanced glycation end-product (AGE), which was determined by fluorescence at 370 nm excitation and 440 nm emission wavelength, increased and intermolecular cross-links appeared in the GA-modified proteins. To a large extent, aminoguanidine restored the structural alterations and functional deteriorations described above. We conclude that GA-modified matrix proteins diminish their functional properties against mesangial cells and affect cellular functions.
Similar articles
-
Effects of nonenzymatic glycosylation of mesangial matrix on proliferation of mesangial cells.Diabetes. 1991 May;40(5):540-7. doi: 10.2337/diab.40.5.540. Diabetes. 1991. PMID: 1708734
-
Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism.Diabetes. 1997 Nov;46(11):1881-7. doi: 10.2337/diab.46.11.1881. Diabetes. 1997. PMID: 9356040
-
Rat mesangial cell-matrix interactions in culture.Exp Cell Res. 1989 Oct;184(2):484-98. doi: 10.1016/0014-4827(89)90346-7. Exp Cell Res. 1989. PMID: 2553458
-
Inhibition of matrix-induced bone differentiation by advanced glycation end-products in rats.Diabetologia. 1993 Sep;36(9):802-7. doi: 10.1007/BF00400353. Diabetologia. 1993. PMID: 8405750
-
Heparin, a possible therapy for diabetic complications: the effect on mesangial and myomedial cells in vivo and in vitro, especially in relation to extracellular matrix.J Diabetes Complications. 1995 Apr-Jun;9(2):97-103. doi: 10.1016/1056-8727(94)00003-7. J Diabetes Complications. 1995. PMID: 7599355 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources